earticle

논문검색

Plenary Lecture, Chair : Chair : Gyun Min Lee (KAIST, Korea)

Protein-based cellular alchemy for personalized medicine

초록

영어

The induced pluripotent stem cell (iPSC) technology pioneered by Yamanaka and his colleagues in 2006 has ignited an explosion of scientific and public interest because these cells can potentially offer an ideal cell source to study and treat numerous human diseases by providing patient- and disease-specific cells. However, widely established methods to generate iPSCs require the use of viral and/or genetic materials that likely integrate into the chromosomal DNAs with unknown genetic changes. Indeed, recent evidence demonstrated that viral-based iPS cells compromise genomic integrity and exhibit abnormal phenotypes. Thus, to realize the therapeutic and biomedical potentials of iPSCs, it is critical to develop reprogramming methods that can avoid or minimize these potential abnormalities. As a potential approach, we attempted to generate iPSCs without the use of viruses or DNA transfection by directly delivering four reprogramming proteins (Oct4, Sox2, Klf4, and c-Myc) fused with a cell penetrating peptide. We also characterized these protein-based iPSCs along with virus-based iPSCs for their molecular and differentiation properties. This presentation will discuss current limitations as well as the potential of protein-based iPSC reprogramming with the long-term goal to use them for eventual personalized medicine.

저자정보

  • Kwang-Soo KIM Molecular Neurobiology Laboratory, Program in Neuroscience and Harvard Stem Cell Institute, McLean Hospital/Harvard Medical School.

참고문헌

자료제공 : 네이버학술정보

    함께 이용한 논문

      ※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.

      0개의 논문이 장바구니에 담겼습니다.